Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue
The invention provides a blend of amino acid powders that have been exposed to pulsed laser radiation. The pulsed laser radiation is obtained by passing laser radiation through a device, which has a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings. Passing the laser radiation through the device cancels a portion of the laser radiation by destructive interference, and produces pulses of laser radiation by constructive interference. The blend of laser treated amino acids has been found useful in regenerating active myocardial tissue. The invention further provides a process for preparing the laser treated blend of amino acid powders and a method of regenerating active myocardial tissue with the blend.
1. A blend of amino acids, comprising a plurality of amino acid powders exposed to pulsed laser radiation, the pulsed laser radiation obtained by passing laser radiation through a device comprising a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings, thereby canceling a portion of the laser radiation by destructive interference, and producing pulses of laser radiation by constructive interference.
2. The blend of amino acids according to claim 1 , wherein the pulsed laser radiation has a pulse length of no more than 10 −9 seconds.
3. The blend of amino acids according to claim 1 , wherein the laser radiation with a laser having a center frequency of about 400 to about 550 nm.
4. The blend of amino acids according to claim 1 , wherein the plurality of amino acid powders comprises glycine, DL-phenylalanine, L-glutamic acid, L-lysine, L-glutamine, L-arginine, L-leucine, L-isoleucine, L-valine, L-methionine, L-serine, L-threonine, L-alanine, L-aspartic acid, L-histidine, L-proline, L-ornithine, L-citrulline, L-taurine, and L-cysteine.
5. The blend of amino acids according to claim 1 , wherein the plurality of amino acid powders comprises 34.1±3.4 percent by weight glycine, 11.9±1.19 percent by weight DL-phenylalanine, 6.3±0.63 percent by weight L-glutamic acid, 6.3±0.63 percent by weight L-lysine, 6.3±0.63 percent by weight L-glutamine, 5.6±0.56 percent by weight L-arginine, 5.6±0.56 percent by weight L-leucine, 3.7±0.37 percent by weight L-isoleucine, 3.1±0.31 percent by weight L-valine, 3.1±0.31 percent by weight L-methionine, 3.1±0.31 percent by weight L-serine, 2.5±0.25 percent by weight L-threonine, 1.6±0.16 percent by weight L-alanine, 1.3±0.13 percent by weight L-aspartic acid, 1.3±0.13 percent by weight L-histidine, 1.3±0.13 percent by weight L-proline, 1.1±0.011 percent by weight L-ornithine, 0.9±0.09 percent by weight L-citrulline, 0.6±0.06 percent by weight L-taurine, and 0.3±0.03 percent by weight L-cysteine.
6. The blend of amino acids according to claim 1 , wherein the plurality of amino acid powders comprises about 34.1 percent by weight glycine, about 11.9 percent by weight DL-phenylalanine, about 6.3 percent by weight L-glutamic acid, about 6.3 percent by weight L-lysine, about 6.3 percent by weight L-glutamine, about 5.6 percent by weight L-arginine, about 5.6 percent by weight L-leucine, about 3.7 percent by weight L-isoleucine, about 3.1 percent by weight L-valine, about 3.1 percent by weight L-methionine, about 3.1 percent by weight L-serine, about 2.5 percent by weight L-threonine, about 1.6 percent by weight L-alanine, about 1.3 percent by weight L-aspartic acid, about 1.3 percent by weight L-histidine, about 1.3 percent by weight L-proline, about 1.1 percent by weight L-ornithine, about 0.9 percent by weight L-citrulline, about 0.6 percent by weight L-taurine, and about 0.3 percent by weight L-cysteine.
7. A process for preparing a laser treated blend of amino acids, comprising:
obtaining a blend of amino acid powders; and
exposing the blend of amino acids to pulsed laser radiation, the pulsed laser radiation obtained by passing laser radiation through a device comprising a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings, thereby canceling a portion of the laser radiation by destructive interference, and producing pulses of laser radiation by constructive interference.
8. The process according to claim 7 , wherein the blend of amino acid powders comprises glycine, DL-phenylalanine, L-glutamic acid, L-lysine, L-glutamine, L-arginine, L-leucine, L-isoleucine, L-valine, L-methionine, L-serine, L-threonine, L-alanine, L-aspartic acid, L-histidine, L-proline, L-ornithine, L-citrulline, L-taurine, and L-cysteine.
9. The process according to claim 7 , wherein the plurality of amino acid powders comprises 34.1±3.4 percent by weight glycine, 11.9±1.19 percent by weight DL-phenylalanine, 6.3±0.63 percent by weight L-glutamic acid, 6.3±0.63 percent by weight L-lysine, 6.3±0.63 percent by weight L-glutamine, 5.6±0.56 percent by weight L-arginine, 5.6±0.56 percent by weight L-leucine, 3.7±0.37 percent by weight L-isoleucine, 3.1±0.31 percent by weight L-valine, 3.1±0.31 percent by weight L-methionine, 3.1±0.31 percent by weight L-serine, 2.5±0.25 percent by weight L-threonine, 1.6±0.16 percent by weight L-alanine, 1.3±0.13 percent by weight L-aspartic acid, 1.3±0.13 percent by weight L-histidine, 1.3±0.13 percent by weight L-proline, 1.1±0.011 percent by weight L-ornithine, 0.9±0.09 percent by weight L-citrulline, 0.6±0.06 percent by weight L-taurine, and 0.3±0.03 percent by weight L-cysteine.
10. The process according to claim 7 , wherein the blend of amino acid powders comprises about 34.1 percent by weight glycine, about 11.9 percent by weight DL-phenylalanine, about 6.3 percent by weight L-glutamic acid, about 6.3 percent by weight L-lysine, about 6.3 percent by weight L-glutamine, about 5.6 percent by weight L-arginine, about 5.6 percent by weight L-leucine, about 3.7 percent by weight L-isoleucine, about 3.1 percent by weight L-valine, about 3.1 percent by weight L-methionine, about 3.1 percent by weight L-serine, about 2.5 percent by weight L-threonine, about 1.6 percent by weight L-alanine, about 1.3 percent by weight L-aspartic acid, about 1.3 percent by weight L-histidine, about 1.3 percent by weight L-proline, about 1.1 percent by weight L-ornithine, about 0.9 percent by weight L-citrulline, about 0.6 percent by weight L-taurine, and about 0.3 percent by weight L-cysteine.
11. The process according to claim 7 , wherein the pulsed laser radiation has a pulse length of no more than 10 −9 second.
12. The process according to claim 7 , further comprising providing the laser radiation with a laser having a center frequency of about 400 to about 550 nm.
13. A method of regenerating active myocardial tissue, comprising administering a blend of amino acids, comprising a plurality of amino acid powders exposed to pulsed laser radiation to a patient, the pulsed laser radiation obtained by passing laser radiation through a device comprising a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings, thereby canceling a portion of the laser radiation by destructive interference, and producing pulses of laser radiation by constructive interference.
14. The method according to claim 13 , wherein the plurality of amino acid powders comprises glycine, DL-phenylalanine, L-glutamic acid, L-lysine, L-glutamine, L-arginine, L-leucine, L-isoleucine, L-valine, L-methionine, L-serine, L-threonine, L-alanine, L-aspartic acid, L-histidine, L-proline, L-ornithine, L-citrulline, L-taurine, and L-cysteine.
15. The method according to claim 13 , wherein the plurality of amino acid powders comprises 34.1±3.4 percent by weight glycine, 11.9±1.19 percent by weight DL-phenylalanine, 6.3±0.63 percent by weight L-glutamic acid, 6.3±0.63 percent by weight L-lysine, 6.3±0.63 percent by weight L-glutamine, 5.6±0.56 percent by weight L-arginine, 5.6±0.56 percent by weight L-leucine, 3.7±0.37 percent by weight L-isoleucine, 3.1±0.31 percent by weight L-valine, 3.1±0.31 percent by weight L-methionine, 3.1±0.31 percent by weight L-serine, 2.5±0.25 percent by weight L-threonine, 1.6±0.16 percent by weight L-alanine, 1.3±0.13 percent by weight L-aspartic acid, 1.3±0.13 percent by weight L-histidine, 1.3±0.13 percent by weight L-proline, 1.1±0.011 percent by weight L-ornithine, 0.9±0.09 percent by weight L-citrulline, 0.6±0.06 percent by weight L-taurine, and 0.3±0.03 percent by weight L-cysteine.
16. The method according to claim 13 , wherein the plurality of amino acid powders comprises about 34.1 percent by weight glycine, about 11.9 percent by weight DL-phenylalanine, about 6.3 percent by weight L-glutamic acid, about 6.3 percent by weight L-lysine, about 6.3 percent by weight L-glutamine, about 5.6 percent by weight L-arginine, about 5.6 percent by weight L-leucine, about 3.7 percent by weight L-isoleucine, about 3.1 percent by weight L-valine, about 3.1 percent by weight L-methionine, about 3.1 percent by weight L-serine, about 2.5 percent by weight L-threonine, about 1.6 percent by weight L-alanine, about 1.3 percent by weight L-aspartic acid, about 1.3 percent by weight L-histidine, about 1.3 percent by weight L-proline, about 1.1 percent by weight L-ornithine, about 0.9 percent by weight L-citrulline, about 0.6 percent by weight L-taurine, and about 0.3 percent by weight L-cysteine.
17. The method according to claim 13 , wherein the pulses of laser radiation have a pulse length of no more than 10 −9 seconds.
18. The method according to claim 13 , wherein the laser radiation with a laser having a center frequency of about 400 to about 550 nm.